Back

Investigating factors associated with the prevalence of IHD among uncontrolled diabetic patients

2 December 2022 (12:47 - 12:53)
Organised by:
Congress Presentation Part of: Coronary Artery Disease / Acute Coronary Syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Mrs Shazwani Shaharuddin

Monash University Malaysia, Selangor (Malaysia)

3 More presentations in this session

Presentation thumbnail
Real-world comparison of intracoronary imaging and fractional flow reserve measurements on outcomes of semi-urgent and elective percutaneous coronary intervention in a multi-ethnic asian population
Doctor R. Soh (Singapore, SG)
Abstract Slides
Presentation thumbnail
The impact of diabetes mellitus on improvement of resting rate pressure product in patients with refractory angina undergone external counter pulsation
Doctor A. Yasmin (Denpasar, ID)
Abstract Slides
Presentation thumbnail
Antithrombotic monotherapy for stable coronary artery disease and atrial fibrillation patients with and without prior coronary artery revascularization: Insights from the AFIRE trial
Professor S. Yasuda (Sendai, JP)
Abstract Slides

Access the full session

Session thumbnail
Coronary Artery Disease / Acute Coronary Syndromes

The Event

Event poster

ESC Asia 2022 with APSC & AFC

2 December 2022 12:47 CET
You may be interested in
thumbnail
Congress Presentation
Uncontrolled diabetes predicts anxiety and depression in CAD patients
27 August 2021
thumbnail
Congress Presentation
Ischemic heart disease is more prevalent in low-income-countries and more often undertreated: data from report-hf
28 August 2020
thumbnail
Congress Presentation
Cardiovascular risk control in community-based Irish adults with hypertension
4 April 2025
thumbnail
Congress Presentation
Prevalence of atrial fibrillation and its associated factors among type 2 diabetics attending a tertiary hospital.
13 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources